Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma

BACKGROUND: Ewing sarcoma is an aggressive, highly metastatic primary bone and soft tissue tumor most frequently occurring in the bone of young adolescents. Patients, especially those diagnosed with a metastatic disease, have a poor overall survival. Chemokine receptor CXCR4 has a key pro-tumorigeni...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Sand, Laurens G. L., Buckle, Tessa, van Leeuwen, Fijs W. B., Corver, Willem E., Kruisselbrink, Alwine B., Jochemsen, Aart G., Hogendoorn, Pancras C. W., Szuhai, Károly
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446759/
https://ncbi.nlm.nih.gov/pubmed/28549419
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3352-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi